• Title: Javelin Pharmaceuticals Hosts Quarterly Conference Call
• Artist: Zangani Investor Community(TM)
• Year: 2007
• Length: 49:41 minutes (11.38 MB)
• Format: Mono 22kHz 32Kbps (CBR)

Today Dr. Daniel B. Carr, CEO and CMO, and Stephen J. Tulipano, CPA, CFO, hosted a conference call discussing the Company's quarterly results for the period ending September 30, 2007.

Javelin Participants:

Dr. Daniel B. Carr, CEO and CMO; Fred Mermelstein, Ph.D., President; Stephen J. Tulipano, CPA, CFO; David B. Bernstein, Esq., General Counsel and Chief IP Counsel; Dr. Curtis Wright, IV, MPH, EVP, Risk Management and Regulatory Affairs and Rick Pierce, VP Investor Relations.

About Javelin Pharmaceuticals, Inc.:

Javelin is a specialty pharmaceutical company that applies proprietary technologies to develop new drugs and improved formulations of existing drugs for pain management. Specialty pharmaceutical analysts from six investment firms cover Javelin Pharmaceuticals, Inc. Javelin's headquarters are located in Cambridge, Massachusetts with European offices in Cambridge, England and Cologne, Germany. For additional information, visit www.javelinpharmaceuticals.com.